Randomised Trial of Tenectplase Versus Alteplase for Acute Stroke within 4.5h of Onset: The Second Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST-2)

Keith T. Muir, Gary A. Ford, Ian Ford, Joanna M. Wardlaw, Alex McConnachie, Nicola Greenlaw, Grant Mair, Nikola Sprigg, Christopher Price, Mary Joan MacLeod, Sofia Dima, Marius Venter, Liqun Zhang, Eoin O’Brien, Ranjan Sanyal, John Reid, L. Sztriha, Syed Haider, William Whiteley, James Kennedy, Richard Perry, Lakshmanan Sekaran, Annie Chakrabarti, Ahamad Hassan, Richard Marigold, Senthil Raghunathan, Don Sims, Mohit Bhandari, Ivan Wiggam, Khalid Rashed, Chris Douglass, Attest- InvestigatorsSSRN 2024 · DOI

BibTeX
@misc{muir2024randomised,
  author = {Keith T. Muir and Gary A. Ford and Ian Ford and Joanna M. Wardlaw and Alex McConnachie and Nicola Greenlaw and Grant Mair and Nikola Sprigg and Christopher Price and Mary Joan MacLeod and Sofia Dima and Marius Venter and Liqun Zhang and Eoin O’Brien and Ranjan Sanyal and John Reid and L. Sztriha and Syed Haider and William Whiteley and James Kennedy and Richard Perry and Lakshmanan Sekaran and Annie Chakrabarti and Ahamad Hassan and Richard Marigold and Senthil Raghunathan and Don Sims and Mohit Bhandari and Ivan Wiggam and Khalid Rashed and Chris Douglass and ATTEST- Investigators},
  title = {{Randomised Trial of Tenectplase Versus Alteplase for Acute Stroke within 4.5h of Onset: The Second Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST-2)}},
  year = {2024},
  doi = {10.2139/ssrn.4831843},
  howpublished = {SSRN},
}

Loading related content...

Figure